EXPRESSION OF CONCERN: Clinical significance and safety profile of antibody-drug conjugates in malignancies of the female reproductive system

The editors express concern regarding the following review article: Uzdenova D.M., Timofeeva E.A., Isaev D.M., Mestoeva Z.B., Evsikova E.R., Kuznetsova A.A., Zabelin N.V., Kovalenko Yu.V., Kuznetsov D.S., Bembeeva A.E., Monid K.A., Koleukho A.V., Gil U.M. Clinical significance and safety profile of antibody-drug conjugates in malignancies of the female reproductive system. Obstetrics, Gynecology and Reproduction. 2026;20(4):802–819. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2026.769. The reason was doubts about compliance with publication ethics, concerning the authorship and documents authenticity. Currently the editorial board is conducting a revision in accordance with the Committee on Publication Ethics (COPE) recommendations. Until the examination is completed, readers are recommended to interpret the contents of this review taking these circumstances into account.

1. Uzdenova D.M., Timofeeva E.A., Isaev D.M., Mestoeva Z.B., Evsikova E.R., Kuznetsova A.A., Zabelin N.V., Kovalenko Yu.V., Kuznetsov D.S., Bembeeva A.E., Monid K.A., Koleukho A.V., Gil U.M. Clinical significance and safety profile of antibody-drug conjugates in malignancies of the female reproductive system. Obstetrics, Gynecology and Reproduction. 2026;20(4):802–819. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2026.769.

2. Makatsariya A.D., Vorobev A.V. From clinical observation to digital prediction: research in contemporary obstetrics, gynecology, and reproduction. Obstetrics, Gynecology and Reproduction. 2026;20(3):402–408. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2026.786.